The Enzymatic Basis of Drug-Drug Interactions with Systemic Triazole Antifungals
✍ Scribed by Dr Yasmine Nivoix, Dominique Levêque, Raoul Herbrecht, Jean-Claude Koffel, Laurence Beretz, Genevieve Ubeaud-Sequier
- Book ID
- 119929118
- Publisher
- Springer International Publishing AG
- Year
- 2008
- Tongue
- English
- Weight
- 168 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0312-5963
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Previous studies implicated the cytochrome P450 (CYP) system as critical in the teratogenic bioactivation of phenytoin (PHT). Fluconazole (FCZ) is an antifungal bis-triazole with potent inhibitory effect on the principal CYP-dependent metabolic pathway of PHT. In this study an in vivo experimental m
The newer oral antifungal agents, such as fluconazole, itraconazole and terbinafine, are generally both effective and well tolerated in the management of widespread or resistant dermatomycoses such as onychomycosis. However, these agents differ markedly in their potential to cause clinically signifi
The Role Of Medicinal Chemistry In Drug Discovery / John A. Lowe Iii -- Process Research: How Much? How Soon? / Neal G. Anderson -- Aromatase Inhibitors For Breast Cancer : Exemestane (aromasin), Anastrozole (arimidex), And Letrozole (femara) / Jie Jack Li -- Quinolone Antibiotics : Levofloxacin (le